Quick Search

 

 


 

 

Home > Result Summaries: Compounds > lapatinib > Result Summary for 113349

Result Summary for 113349

Result Summary
Protocol ID: 113349
Clinical Study ID: WWE113349
Official Title: Breast cancer with over-expression of erbB2 study of the treatment paradigm in metastasis to BRAIN (BRAINSTORM)
Phase: n\a
Study Indications or Diseases:
  • Cancer
Generic Name: lapatinib
Trade/Product Name: Tyverb,Tykerb,Tycerb
Approved Drug Label: http://www.gsk.com/products.html
Results Summary: Click here to download result summary. Click here to download result summary.
Citations:
  • Yap YS, Cornelio GH, Devi BCR, Khorprasert C, Kim SB, Kim, TY, Lee SC, Park YH, Sohn JH, Sutandyo N, Wai D, Wong DWY, Kobayashi M, Landis SH, Yeo EM, Moon H, Ro J. Brain metastases in Asian HER2-positive breast cancer patients: anti-HER2 treatments and their impact on survival. [Br J Cancer]. 2012;107(7):1075-82.

The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.